Molecular Medicine

, Volume 17, Issue 11–12, pp 1242–1252 | Cite as

A Dual Role for Diacylglycerol Kinase Generated Phosphatidic Acid in Autoantibody-Induced Neutrophil Exocytosis

  • Neil J. Holden
  • Caroline O. S. Savage
  • Stephen P. Young
  • Michael J. Wakelam
  • Lorraine Harper
  • Julie M. Williams
Research Article


Dysregulated release of neutrophil azurophilic granules causes increased tissue damage and amplified inflammation during autoimmune disease. Antineutrophil cytoplasmic antibodies (ANCAs) are implicated in the pathogenesis of small vessel vasculitis and promote adhesion and exocytosis in neutrophils. ANCAs activate specific signal transduction pathways in neutrophils that have the potential to be modulated therapeutically to prevent neutrophil activation by ANCAs. We have investigated a role for diacylglycerol kinase (DGK) and its downstream product phosphatidic acid (PA) in ANCA-induced neutrophil exocytosis. Neutrophils incubated with the DGK inhibitor R59022, before treatment with ANCAs, exhibited a reduced capacity to release their azurophilic granules, demonstrated by a component release assay and flow cytometry. PA restored azurophilic granule release in DGK-inhibited neutrophils. Confocal microscopy revealed that R59022 did not inhibit translocation of granules, indicating a role for DGK during the process of granule fusion at the plasma membrane. In investigating possible mechanisms by which PA promotes neutrophil exocytosis, we demonstrated that exocytosis can only be restored in R59022-treated cells through simultaneous modulation of membrane fusion and increasing cytosolic calcium. PA and its associated pathways may represent viable drug targets to reduce tissue injury associated with ANCA-associated vasculitic diseases and other neutrophilic inflammatory disorders.



The work was funded by a Stuart Strange Vasculitis Trust postdoctoral fellowship.


  1. 1.
    Lacy P. (2005) The role of Rho GTPases and SNAREs in mediator release from granulocytes. Pharmacol. Ther. 107:358–76.CrossRefGoogle Scholar
  2. 2.
    Mollinedo F, et al. (2006) Combinatorial SNARE complexes modulate the secretion of cytoplasmic granules in human neutrophils. J. Immunol. 177:2831–41.CrossRefGoogle Scholar
  3. 3.
    Mitchell T, Lo A, Logan MR, Lacy P, Eitzen G. (2008) Primary granule exocytosis in human neutrophils is regulated by Rac-dependent actin remodeling. Am. J. Physiol. Cell. Physiol. 295:C1354–65.CrossRefPubMedCentralGoogle Scholar
  4. 4.
    Pak V, Budikhina A, Pashenkov M, Pinegin B. (2007) Neutrophil activity in chronic granulomatous disease. Adv. Exp. Med. Biol. 601:69–74.CrossRefGoogle Scholar
  5. 5.
    Paulino EC, de Souza LJ, Molan NA, Machado MC, Jancar S. (2007) Neutrophils from acute pancreatitis patients cause more severe in vitro endothelial damage compared with neutrophils from healthy donors and are differently regulated by endothelins. Pancreas. 35:37–41.CrossRefGoogle Scholar
  6. 6.
    Pankhurst T, Savage CO. (2006) Pathogenic role of anti-neutrophil cytoplasmic antibodies in vasculitis. Curr. Opin. Pharmacol. 6:190–6.CrossRefGoogle Scholar
  7. 7.
    Lu X, Garfield A, Rainger GE, Savage CO, Nash GB. (2006) Mediation of endothelial cell damage by serine proteases, but not superoxide, released from antineutrophil cytoplasmic antibody-stimulated neutrophils. Arthritis Rheum. 54:1619–28.CrossRefGoogle Scholar
  8. 8.
    Baldus S, et al. (2001) Endothelial transcytosis of myeloperoxidase confers specificity to vascular ECM proteins as targets of tyrosine nitration. J. Clin. Invest. 108:1759–70.CrossRefPubMedCentralGoogle Scholar
  9. 9.
    Astern JM, et al. (2007) Myeloperoxidase interacts with endothelial cell-surface cytokeratin 1 and modulates bradykinin production by the plasma Kallikrein-Kinin system. Am. J. Pathol. 171:349–60.CrossRefPubMedCentralGoogle Scholar
  10. 10.
    Ben Smith A, Dove SK, Martin A, Wakelam MJ, Savage CO. (2001) Antineutrophil cytoplasm autoantibodies from patients with systemic vasculitis activate neutrophils through distinct signaling cascades: comparison with conventional Fcgamma receptor ligation. Blood. 98:1448–55.CrossRefGoogle Scholar
  11. 11.
    Williams JM, et al. (2003) Activation of the G(i) heterotrimeric G protein by ANCA IgG F(ab′)2 fragments is necessary but not sufficient to stimulate the recruitment of those downstream mediators used by intact ANCA IgG. J. Am. Soc. Nephrol. 14:661–9.CrossRefGoogle Scholar
  12. 12.
    Hewins P, Williams JM, Wakelam MJ, Savage CO. (2004) Activation of Syk in neutrophils by antineutrophil cytoplasm antibodies occurs via Fcgamma receptors and CD18. J. Am. Soc. Nephrol. 15:796–808.CrossRefGoogle Scholar
  13. 13.
    Williams JM, et al. (2007) Antineutrophil cytoplasm antibody-stimulated neutrophil adhesion depends on diacylglycerol kinase-catalyzed phosphatidic acid formation. J. Am. Soc. Nephrol. 18:1112–20.CrossRefGoogle Scholar
  14. 14.
    Pettitt TR, et al. (1997) Diacylglycerol and phosphatidate generated by phospholipases C and D, respectively, have distinct fatty acid compositions and functions: phospholipase D-derived diacylglycerol does not activate protein kinase C in porcine aortic endothelial cells. J. Biol. Chem. 272:17354–9.CrossRefGoogle Scholar
  15. 15.
    Wakelam MJ. (1998) Diacylglycerol: when is it an intracellular messenger? Biochim. Biophys. Acta. 1436:117–26.CrossRefGoogle Scholar
  16. 16.
    Lominadze G, et al. (2005) Proteomic analysis of human neutrophil granules. Mol. Cell Proteomics. 4:1503–21.CrossRefGoogle Scholar
  17. 17.
    Jepsen LV, Skottun T. (1982) A rapid one-step method for the isolation of human granulocytes from whole blood. Scand. J. Clin. Lab. Invest. 42:235–8.CrossRefGoogle Scholar
  18. 18.
    de Chaffoy de Courcelles DC, Roevens P, Van Belle H. (1985) R 59 022, a diacylglycerol kinase inhibitor: its effect on diacylglycerol and thrombin-induced C kinase activation in the intact platelet. J. Biol. Chem. 260:15762–70.PubMedGoogle Scholar
  19. 19.
    Jiang Y, Sakane F, Kanoh H, Walsh JP. (2000) Selectivity of the diacylglycerol kinase inhibitor 3-[2-(4-[bis-(4-fluorophenyl)methylene]-1-piperidinyl)ethyl]-2, 3-dihydro-2-thioxo-4(1H)quinazolinone (R59949) among diacylglycerol kinase subtypes. Biochem. Pharmacol. 59:763–72.CrossRefGoogle Scholar
  20. 20.
    Agwu DE, McPhail LC, Wykle RL, McCall CE. (1989) Mass determination of receptor-mediated accumulation of phosphatidate and diglycerides in human neutrophils measured by Coomassie blue staining and densitometry. Biochem. Biophys. Res. Commun. 159:79–86.CrossRefGoogle Scholar
  21. 21.
    Rabinovitch PS, June CH, Grossmann A, Ledbetter JA. (1986) Heterogeneity among T cells in intracellular free calcium responses after mitogen stimulation with PHA or anti-CD3: simultaneous use of indo-1 and immunofluorescence with flow cytometry. J. Immunol. 137:952–61.PubMedGoogle Scholar
  22. 22.
    Carruthers DM, Arrol HP, Bacon PA, Young SP (2000) Dysregulated intracellular Ca2+ stores and Ca2+ signaling in synovial fluid T lymphocytes from patients with chronic inflammatory arthritis. Arthritis Rheum. 43:1257–65.CrossRefGoogle Scholar
  23. 23.
    Rainger GE, Rowley AF, Nash GB. (1998) Adhesion-dependent release of elastase from human neutrophils in a novel, flow-based model: specificity of different chemotactic agents. Blood. 92:4819–27.PubMedGoogle Scholar
  24. 24.
    Ting-Beall HP, Lee AS, Hochmuth RM. (1995) Effect of cytochalasin D on the mechanical properties and morphology of passive human neutrophils. Ann. Biomed. Eng. 23:666–71.CrossRefGoogle Scholar
  25. 25.
    Jog NR, et al. (2007) The actin cytoskeleton regulates exocytosis of all neutrophil granule subsets. Am. J. Physiol. Cell Physiol. 292:C1690–700.CrossRefGoogle Scholar
  26. 26.
    Sheikh S, Gratzer WB, Pinder JC, Nash GB. (1997) Actin polymerisation regulates integrin-mediated adhesion as well as rigidity of neutrophils. Biochem. Biophys. Res. Commun. 238:910–15.CrossRefGoogle Scholar
  27. 27.
    Anderson SI, Behrendt B, Machesky LM, Insall RH, Nash GB. (2003) Linked regulation of motility and integrin function in activated migrating neutrophils revealed by interference in remodelling of the cytoskeleton. Cell Motil. Cytoskeleton. 54:135–46.CrossRefGoogle Scholar
  28. 28.
    Pagano RE, Longmuir KJ, Martin OC. (1983) Intracellular translocation and metabolism of a fluorescent phosphatidic acid analogue in cultured fibroblasts. J. Biol. Chem. 258:2034–40.PubMedGoogle Scholar
  29. 29.
    Kooijman EE, et al. (2005) Spontaneous curvature of phosphatidic acid and lysophosphatidic acid. Biochemistry. 44:2097–102.CrossRefGoogle Scholar
  30. 30.
    Zeniou-Meyer M, et al. (2007) Phospholipase D1 production of phosphatidic acid at the plasma membrane promotes exocytosis of large densecore granules at a late stage. J. Biol. Chem. 282:21746–57.CrossRefGoogle Scholar
  31. 31.
    Logan MR, Odemuyiwa SO, Moqbel R. (2003) Understanding exocytosis in immune and inflammatory cells: the molecular basis of mediator secretion. J. Allergy Clin. Immunol. 111:923–32.CrossRefGoogle Scholar
  32. 32.
    Williams JM, et al. (2003) Activation of the G(i) heterotrimeric G protein by ANCA IgG F(ab′)2 fragments is necessary but not sufficient to stimulate the recruitment of those downstream mediators used by intact ANCA IgG. J. Am. Soc. Nephrol. 14:661–9.CrossRefGoogle Scholar
  33. 33.
    David A, Fridlich R, Aviram I (2005) The presence of membrane proteinase 3 in neutrophil lipid rafts and its colocalization with FcgammaRIIIb and cytochrome b558. Exp. Cell Res. 308:156–65.CrossRefGoogle Scholar
  34. 34.
    Skubitz KM, Campbell KD, Skubitz AP. (2000) CD63 associates with CD11/CD18 in large detergent-resistant complexes after translocation to the cell surface in human neutrophils. FEBS Lett. 469:52–6.CrossRefGoogle Scholar
  35. 35.
    Skubitz KM, Campbell KD, Iida J, Skubitz AP. (1996) CD63 associates with tyrosine kinase activity and CD11/CD18, and transmits an activation signal in neutrophils. J. Immunol. 157:3617–26.PubMedGoogle Scholar
  36. 36.
    Sollner T, Bennett MK, Whiteheart SW, Scheller RH, Rothman JE. (1993) A protein assembly-disassembly pathway in vitro that may correspond to sequential steps of synaptic vesicle docking, activation, and fusion. Cell. 75:409–18.CrossRefGoogle Scholar
  37. 37.
    Lee AG. (2004) How lipids affect the activities of integral membrane proteins. Biochim. Biophys. Acta. 1666:62–87.CrossRefGoogle Scholar
  38. 38.
    Dickey A, Faller R. (2008) Examining the contributions of lipid shape and headgroup charge on bilayer behavior. Biophys. J. 95:2636–46.CrossRefPubMedCentralGoogle Scholar
  39. 39.
    Vicogne J, et al. (2006) Asymmetric phospholipid distribution drives in vitro reconstituted SNARE-dependent membrane fusion. Proc. Natl. Acad. Sci. U. S. A. 103:14761–6.CrossRefPubMedCentralGoogle Scholar
  40. 40.
    Lam AD, Tryoen-Toth P, Tsai B, Vitale N, Stuenkel EL. (2008) SNARE-catalyzed fusion events are regulated by syntaxin1A-lipid interactions. Mol. Biol. Cell. 19:485–97.CrossRefPubMedCentralGoogle Scholar
  41. 41.
    Siddiqui RA, English D. (1996) Phosphatidic acid binding to human neutrophils: effects on tyrosine kinase-regulated intracellular Ca2+ mobilization. Cell Signal. 8:349–54.CrossRefGoogle Scholar
  42. 42.
    Wadel K, Neher E, Sakaba T. (2007) The coupling between synaptic vesicles and Ca2+ channels determines fast neurotransmitter release. Neuron. 53:563–75.CrossRefGoogle Scholar
  43. 43.
    Korchak HM, et al. (1988) Activation of the human neutrophil by calcium-mobilizing ligands. II. Correlation of calcium, diacyl glycerol, and phosphatidic acid generation with superoxide anion generation. J. Biol. Chem. 263:11098–105.PubMedGoogle Scholar
  44. 44.
    Fernandez-Chacon R, et al. (2001) Synaptotagmin I functions as a calcium regulator of release probability. Nature. 410:41–9.CrossRefGoogle Scholar
  45. 45.
    Stein A, Radhakrishnan A, Riedel D, Fasshauer D, Jahn R. (2007) Synaptotagmin activates membrane fusion through a Ca2+-dependent trans interaction with phospholipids. Nat. Struct. Mol. Biol. 14:904–11.CrossRefGoogle Scholar
  46. 46.
    Martens S, Kozlov MM, McMahon HT. (2007) How synaptotagmin promotes membrane fusion. Science. 316:1205–8.CrossRefGoogle Scholar
  47. 47.
    Agwu DE, McPhail LC, Sozzani S, Bass DA, McCall CE. (1991) Phosphatidic acid as a second messenger in human polymorphonuclear leukocytes: effects on activation of NADPH oxidase. J. Clin. Invest. 88:531–9.CrossRefPubMedCentralGoogle Scholar
  48. 48.
    Mahadevappa VG. (1988) [3H]phosphatidic acid formed in response to FMLF is not inhibited by R59 022, a diacylglycerol kinase inhibitor. Biochem. Biophys. Res. Commun. 153:1097–104.CrossRefGoogle Scholar
  49. 49.
    Rossi F, Grzeskowiak M, Della Bianca V, Calzetti F, Gandini G. (1990) Phosphatidic acid and not diacylglycerol generated by phospholipase D is functionally linked to the activation of the NADPH oxidase by FMLF in human neutrophils. Biochem. Biophys. Res. Commun. 168:320–7.CrossRefGoogle Scholar
  50. 50.
    Siddiqui RA, English D. (1997) Phosphatidic acid elicits calcium mobilization and actin polymerization through a tyrosine kinase-dependent process in human neutrophils: a mechanism for induction of chemotaxis. Biochim. Biophys. Acta. 1349:81–95.CrossRefGoogle Scholar
  51. 51.
    Nishikimi A, et al. (2009) Sequential regulation of DOCK2 dynamics by two phospholipids during neutrophil chemotaxis. Science. 324:384–7.PubMedPubMedCentralGoogle Scholar
  52. 52.
    Srinivasan S, et al. (2003) Rac and Cdc42 play distinct roles in regulating PI(3,4,5)P3 and polarity during neutrophil chemotaxis. J. Cell Biol. 160:375–85.CrossRefPubMedCentralGoogle Scholar
  53. 53.
    Cipres A, et al. (2003) Regulation of diacylglycerol kinase alpha by phosphoinositide 3-kinase lipid products. J. Biol. Chem. 278:35629–35.CrossRefGoogle Scholar
  54. 54.
    Cutrupi S, et al. (2000) Src-mediated activation of alpha-diacylglycerol kinase is required for hepatocyte growth factor-induced cell motility. EMBO J. 19:4614–22.CrossRefPubMedCentralGoogle Scholar
  55. 55.
    Hodgkin MN, et al. (1998) Diacylglycerols and phosphatidates: which molecular species are intracellular messengers? Trends Biochem. Sci. 23:200–4.CrossRefGoogle Scholar
  56. 56.
    Siddiqui RA, English D. (2000) Phosphatidylinositol 3′-kinase-mediated calcium mobilization regulates chemotaxis in phosphatidic acid-stimulated human neutrophils. Biochim. Biophys. Acta. 1483:161–73.CrossRefGoogle Scholar
  57. 57.
    Winter JN, Fox TE, Kester M, Jefferson LS, Kimball SR. (2010) Phosphatidic acid mediates activation of mTORC1 through the ERK signaling pathway. Am. J. Physiol. Cell Physiol. 299:C335–44.CrossRefPubMedCentralGoogle Scholar
  58. 58.
    Delon C, et al. (2004) Sphingosine kinase 1 is an intracellular effector of phosphatidic acid. J. Biol. Chem. 279:44763–74.CrossRefGoogle Scholar
  59. 59.
    Aas V, Algeroy S, Sand KL, Iversen JG. (2001) Fibronectin promotes calcium signaling by interferon-gamma in human neutrophils via G-protein and sphingosine kinase-dependent mechanisms. Cell Commun. Adhes. 8:125–38.CrossRefGoogle Scholar
  60. 60.
    Itagaki K, Hauser CJ. (2003) Sphingosine 1-phosphate, a diffusible calcium influx factor mediating store-operated calcium entry. J. Biol. Chem. 278:27540–7.CrossRefPubMedCentralGoogle Scholar

Copyright information

© The Feinstein Institute for Medical Research 2011

Authors and Affiliations

  • Neil J. Holden
    • 1
  • Caroline O. S. Savage
    • 1
  • Stephen P. Young
    • 2
  • Michael J. Wakelam
    • 3
  • Lorraine Harper
    • 1
  • Julie M. Williams
    • 4
  1. 1.Renal Immunobiology, School of Immunity and InfectionUniversity of BirminghamBirminghamUK
  2. 2.Rheumatology Research Group, School of Immunity and InfectionUniversity of BirminghamBirminghamUK
  3. 3.Inositide LaboratoryBabraham InstituteCambridgeUK
  4. 4.Wellcome Trust Clinical Research FacilityUniversity Hospital Birmingham Foundation TrustBirminghamUK

Personalised recommendations